
ANI Pharmaceuticals Announces Results From NEW DAY Clinical Trial Of ILUVIEN® For Use In Patients With Diabetic Macular ...
(MENAFN- GlobeNewsWire - Nasdaq) Trial evaluated number of supplemental injections needed for the treatment of DME for patients on ILUVIEN versus the aflibercept arm Study Enrolled Treatment-Naïve, or Almost Naïve, Patients with DME Results presented by …